| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2K | -53.5% | — |
| Cost of Revenue | $477 | -49.1% | -12.8% |
| Gross Profit | $2K | -54.6% | +409.0% |
| R&D Expense | $2.0M | +4.1% | -1.6% |
| SG&A Expense | $795K | -56.7% | -21.7% |
| Operating Income | -$2.8M | +25.7% | +8.4% |
| Pre-tax Income | -$2.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.1M | -7.8% | -78.1% |
| Accounts Receivable | $62 | -66.8% | — |
| Inventory | $167K | +4.3% | +3.8% |
| Current Assets | $1.7M | -0.8% | -69.5% |
| Total Assets | $22.7M | -5.2% | -27.7% |
| Current Liabilities | $581K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | — |
| Capital Expenditures | $36K | — | — |
| Investing Cash Flow | -$13K | — | — |
| Financing Cash Flow | $853K | — | — |
| Free Cash Flow | -$3.8M | — | — |
| +20.8% |
| Net Income | -$2.9M | +28.2% | +20.8% |
| EPS (Basic) | -$0.64 | +35.4% | -93.9% |
| EPS (Diluted) | -$0.64 | +35.4% | -93.9% |
| -3.6% |
| -85.9% |
| Total Liabilities | $12.6M | +1.2% | -5.3% |
| Stockholders' Equity | $10.0M | -12.2% | -44.3% |